A systematic evaluation of immunoassay point-of-care testing to define impact on patients’ outcomes
The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Background: Point-of-care testing has been developed to provide rapid test results. Most published studies focus on analytical performance, neglecting its impact on patient outcomes. Objective: To review the analytical performance and accuracy of point-of-care testing specifically planned for immunoassay and to evaluate the impact of faster results on patient management. Methods: A search of electronic databases for studies reporting immunoassay results obtained in both point-of-care testing and central laboratory scenarios was performed. Data were extracted concerning the study details, and the methodological quality was assessed. The analytical characteristics and diagnostic accuracy of six points-of-care testing: troponin, procalcitonin, parathyroid hormone, brain natriuretic peptide, C-reactive protein and neutrophil gelatinase-associated lipocalin were evaluated. Results: A total of 116 scientific papers were analysed. Studies measuring procalcitonin, parathyroid hormone and neutrophil gelatinase-associated lipocalin reported a limited impact on diagnostic decisions. Seven studies measuring C-reactive protein claimed a significant reduction of antibiotic prescription. Several authors evaluated brain natriuretic peptide or troponin reporting faster decision-making without any improvement in clinical outcome. Forty-four per cent of studies reported analytical data, showing satisfactory correlations between results obtained through point-of-care testing and central laboratory setting. Half of studies defined the diagnostic accuracy of point-of-care testing as acceptable for troponin (median sensitivity and specificity: 74% and 94%, respectively), brain natriuretic peptide (median sensitivity and specificity: 82% and 88%, respectively) and C-reactive protein (median sensitivity and specificity 85%). Conclusions: Point-of-care testing immunoassay results seem to be reliable and accurate for troponin, brain natriuretic peptide and C-reactive protein. The satisfactory analytical performance, together with an excellent practicability, suggests that it could be a consistent tool in clinical practice, but data are lacking regarding the patient outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies on POCT issue mostly report analytical performances (central laboratory vs. POCT) which are usually acceptable but do not report patient outcomes assessment [57].”
From Point-of-care testing: state-of-the art and perspectives (2025) · cites this paper as [57]
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Diagnostic point-of-care tests in resource-limited settings
Drain, P. K., Hyle, E. P., Noubary, F., Freedberg, K. A., Wilson, D., Bishai, W. R., Rodriguez, W., & Bassett, I. V. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70250-0 · Cited by 744
Dent, C. L., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M. M., Barasch, J., & Devarajan, P. (2007) · Critical Care · doi:10.1186/cc6192 · Cited by 483 · cited 1×
“NGAL Dent et al.(66) Prospective 120 Paediatric Unclear”
BackgroundHarrison, A., Morrison, L. K., Krishnaswamy, P., Kazanegra, R., Clopton, P., Dao, Q., Hlavin, P., & Maisel, A. S. (2002) · Annals of Emergency Medicine · doi:10.1067/mem.2002.121483 · Cited by 372
Price, C. P. (2001) · BMJ · doi:10.1136/bmj.322.7297.1285 · Cited by 368
McCord, J., Nowak, R. M., McCullough, P. A., Foreback, C., Borzak, S., Tokarski, G., Tomlanovich, M. C., Jacobsen, G., & Weaver, W. D. (2001) · Circulation · doi:10.1161/hc3801.096336 · Cited by 297
Cals, J. W. L., Schot, M. J. C., de Jong, S. A. M., Dinant, G.-J., & Hopstaken, R. M. (2010) · The Annals of Family Medicine · doi:10.1370/afm.1090 · Cited by 211
Point of care testing: randomised controlled trial of clinical outcome
Kendall, J., Reeves, B., & Clancy, M. (1998) · BMJ · doi:10.1136/bmj.316.7137.1052 · Cited by 200
Wieczorek, S. J., Wu, A. H. B., Christenson, R., Krishnaswamy, P., Gottlieb, S., Rosano, T., Hager, D., Gardetto, N., Chiu, A., Ba illy, K. R., et al. (2002) · American Heart Journal · doi:10.1016/s0002-8703(02)80017-5 · Cited by 182
Research works printed but not linked: 11
- Del Ry S, 2001, Clin Chem Lab Med, 39, 446
- Di Somma S, 2015, Clin Chem Lab Med, 43, 507
- Jorgensen B, 2012, Clin Lab, 58, 515
- Prontera C, 2005, Clin Lab, 51, 1274
- Shah K, 2010, West J Emerg Med, 11, 44
- Vogeser M, 2001, Clin Lab, 47, 29
- 10.1067/mhj.2002.125623 · doi:10.1067/mhj.2002.125623 · Paper page
- Papa F, 2012, Clin Lab, 58, 951
- Goldmann BU, 2004, Clin Lab, 50, 1
- Loten C, 2009, EMA, 21, 286
- Monneret D, 2014, Clin Chem Lab Med, 52, e279
Cited by
Acute Stroke Biomarkers: Are We There Yet?
Dagonnier, M., Donnan, G. A., Davis, S. M., Dewey, H. M., & Howells, D. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.619721 · Cited by 140
Point-of-care testing: state-of-the art and perspectives
Plebani, M., Nichols, J. H., Luppa, P. B., Greene, D., Sciacovelli, L., Shaw, J., Khan, A. I., Carraro, P., Freckmann, G., Dimech, W., et al. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-0675 · Cited by 119
Self-citationGandhi, M., Bacchetti, P., Rodrigues, W. C., Spinelli, M. A., Koss, C. A., Drain, P. K., Baeten, J. M., Mugo, N., Ngure, K., Benet, L. Z., et al. (2018) · EClinicalMedicine · doi:10.1016/j.eclinm.2018.08.004 · Cited by 74
AACC guidance document on management of point-of-care testing
Nichols, J. H., Alter, D., Chen, Y., Isbell, T. S., Jacobs, E., Moore, N., & Shajani-Yi, Z. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa059 · Cited by 63
Point-of-Care Troponin Testing during Ambulance Transport to Detect Acute Myocardial Infarction
Stopyra, J. P., Snavely, A. C., Scheidler, J. F., Smith, L. M., Nelson, R. D., Winslow, J. E., Pomper, G. J., Ashburn, N. P., Hendley, N., Riley, R. F., et al. (2020) · Prehospital Emergency Care · doi:10.1080/10903127.2020.1721740 · Cited by 48
Metadata
- Authors
- Pecoraro, V., Banfi, G., Germagnoli, L., & Trenti, T.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Vita-Salute San Raffaele University (IT)
- Synlab Italia, Brescia, Italy
- Department of Laboratory Medicine, Clinical Pathology-Toxicology, Ospedale Civile Sant’Agostino Estense, Modena, Italy
- Corresponding author
- Pecoraro, Valentina
- Venue
- Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Publisher
- SAGE Publications
- Published
- 2017-05-15
- Volume
- 54
- Issue
- 4
- Pages
- 420-431
- ISSN
- 0004-5632 (ISSN-L)
- 1758-1001
- OpenAlex
- W2583469375
- Cited by
- 17
- References
- 130
- Citations by year
- 2026: 1 · 2024: 3 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 1
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Clinical Biochemistry International Journal of Laboratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- point-of-care testing, immunoassay, patient outcomes, diagnostic accuracy, analytical performance, troponin, brain natriuretic peptide, C-reactive protein, procalcitonin, parathyroid hormone, neutrophil gelatinase-associated lipocalin, antibiotic prescribing, central laboratory comparison, clinical decision-making
- MeSH terms
- Clinical Decision-Making, Point-of-Care Testing, Clinical Studies as Topic, Lipocalin-2, C-Reactive Protein, Calcitonin, Humans, Immunoassay, Laboratories, Hospital, Parathyroid Hormone, Sensitivity and Specificity, Troponin, Treatment Outcome, Natriuretic Peptide, Brain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic evaluation of immunoassay point-of-care testing to define impact on patients’ outcomes. https://app.cochat.ai/papers/10.1177/0004563217694377
- The paper
- Pecoraro, V., Banfi, G., Germagnoli, L., & Trenti, T. (2017). A systematic evaluation of immunoassay point-of-care testing to define impact on patients’ outcomes. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. https://doi.org/10.1177/0004563217694377
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.